ChartRow logo
Share this page

REGN — Regeneron Pharmaceuticals Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in REGN be worth today? →
REGN returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$816.10
YTD price return
+5.73%
YTD total return
+6.14%
Next earnings
Oct 30, 2026 · Before open
Market cap
84B
Enterprise value
79B
Shares outstanding
103M
52W low
$575.93
52W high
$859.34
From 52W high
-5.03%
From 52W low
+41.70%
52W range
85%
Beta
0.20

Volume

Rel volume
0.98×
30D volume
731.9K
30D $ vol
567.9M

Insider trading

Insider net 1W
none
Insider net 1M
−$3.2M
Insider net 3M
−$6.5M
Insider net 1Y
−$11.0M

Form 4 transactions by trade date, as filed; latest on file 2026-10-14.

Fundamentals

Sales (ttm)
15.5B
Sales/share
$150.89
EPS (ttm)
$40.40
FCF (ttm)
3.8B
FCF/share
$36.52
Book value/share
$308.01
Net margin
27.86%
ROE
13.65%
ROA
10.37%
Debt / equity
0.06×
Current ratio
3.34

Growth (CAGR, ttm) · 10Y

Sales
+9.30%+7.03%+4.64%+12.82%
Net income
-2.92%+0.23%-6.95%+19.27%
FCF
-2.42%-3.25%+17.30%+13.58%
Shares
-2.86%-1.75%-0.76%-1.21%

Per-share growth (CAGR, ttm) · 10Y

EPS
+1.84%+2.23%-6.22%+20.16%
Sales/share
+12.52%+8.93%+5.44%+14.20%
FCF/share
+0.45%-1.53%+18.20%+14.97%
Book value/share
+9.05%+11.66%+16.85%+24.27%
Dividend/share
+119.61%n/an/an/a
Price
+39.46%+1.73%+6.72%+8.43%
Total return
+40.18%+2.05%+6.92%+8.54%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
20.2×
P/OI (ttm)
21.9×
Fwd P/E
12.8×
P/S (ttm)
5.4×
P/B (mrq)
2.6×
P/FCF (ttm)
22.3×
EV/EBITDA (fy)
18.1×
EV/Sales (ttm)
5.1×
FCF yield (ttm)
4.48%
Dividend yield (fwd)
0.46%
Dividend yield (ttm)
0.45%
Dividend/share (fwd)
$3.76
Buyback yield (realized, 1y)
2.86%
Shareholder yield (realized, 1y)
3.54%
Buyback yield (cash, ttm)
3.03%
Shareholder yield (cash, ttm)
3.48%

Vs own 10Y history

P/E
55th
P/OI
70th
P/S
30th
P/B
17th
P/FCF
47th

Bar = where today’s multiple sits in REGN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-27#

1D
+1.04%
5D
+1.07%
1M
+3.56%
3M
+22.32%
YTD
+5.73%
1Y
+39.43%
5Y
+38.42%

Recent filings#

All filings and insider trades →

Financial statements

Open full REGN financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+8.32%+0.22%
JNJJohnson & Johnson-0.92%+0.91%
ABBVAbbVie Inc.+8.34%-0.12%
UNHUnitedHealth Group Incorporated Common Stock (DE)+8.98%-0.08%
MRKMerck & Co. Inc.-4.68%+0.86%
NVSNovartis AG+7.84%+1.98%
TMOThermo Fisher Scientific Inc.+2.67%+1.19%
AMGNAmgen Inc.+8.04%+0.75%